Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Revamp Of Small Business Funding Scheme Set For Yet Another Delay By Congress

This article was originally published in The Pink Sheet Daily

Executive Summary

SBIR update: House and Senate can't agree in time on bill prized by cash-hungry biotech industry. End-of-January deadline is set to slide.

You may also be interested in...



Health Reform 101: Cashing In On Hidden Financial Aid Provisions

Biopharmas could win grants equivalent to half of their research expenses in 2009 and 2010, plus apply for a slice of the $500 million in new R&D funding available in areas of high medical need, courtesy of the health reform package

Health Reform 101: Cashing In On Hidden Financial Aid Provisions

Biopharmas could win grants equivalent to half of their research expenses in 2009 and 2010, plus apply for a slice of the $500 million in new R&D funding available in areas of high medical need, courtesy of the health reform package

SBIR reauthorization

Companies seeking Small Business Innovation Research program grant money could be majority-owned by venture capital outfits under the SBIR/STTR Reauthorization Act, S. 3362, approved by the Senate Committee on Small Business and Entrepreneurship July 30. A similar measure was passed by the full House on April 23 (1"The Pink Sheet," April 28, 2008, p. 27). Industry has complained that restrictions on SBIR grants for VC-funded firms detract from the value of the federal program that helps jump-start small company research. The Senate bill would allow no more than 18 percent of National Institutes of Health SBIR funds to go to firms that are majority-owned by venture capitalists

Related Content

Topics

UsernamePublicRestriction

Register

PS070156

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel